OCTREOSCAN DIN 02329271
Health Canada record
| Active ingredient(s) | INDIUM IN 111 CHLORIDE 111 MBq; PENTETREOTIDE 10 MCG |
|---|---|
| Dosage form | Powder For Solution; Solution; Kit |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09IB01 INDIUM 111 IN PENTETREOTIDE |
| Original market date | 06-Oct-2019 |
| Current status date | 06-Oct-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Curium Canada Inc. — licence 3-002566, currently licensed, last inspection rating C (2026-07-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INDIUM IN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02329468 | HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION | CURIUM CANADA INC | Solution | INDIUM IN 111 CHLORIDE 10 MCI | Dormant |
| 02329077 | INDIUM IN-111 CHLORIDE STERILE SOLUTION | GE HEALTHCARE CANADA INC | Solution | INDIUM IN 111 CHLORIDE 74 MBq | Cancelled Pre Market |
| 02329085 | INDIUM IN-111 CHLORIDE STERILE SOLUTION | GE HEALTHCARE CANADA INC | Solution | INDIUM IN 111 CHLORIDE 185 MBq | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22153 | 2019-05-15 | New Drug Submission (NDS) | Administrative - Manufacturer Name Change |
International API supply for INDIUM IN
1 active FDA Drug Master Files.
Request a quote for OCTREOSCAN